Guizhou Chitianhua Co (600227) Fair Value & Analysis
Basic Materials · CN · Market cap 5.3B CNY
Fair value as of: Aug 7, 2026
From 12 valuation models · updated 3 days ago
Share price +39.2% over the past month.
Below-average quality, and screening another 88% overvalued on our models.
What matters now
- The price sits above even our optimistic bull case (¥0.6200). The favourable scenario is already priced in.
- The model range is unusually wide (¥0.2000 to ¥0.6200). The outcome hinges heavily on assumptions, so read the point estimate with caution.
- Solid but not exceptional quality (48/100) and above fair value, neither a clear bargain nor a standout compounder.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 7, 2026.
How to read this chart
60‑month range ¥1.13 – ¥5.29 · fair‑value band ¥0.2000 – ¥0.6200 · the ¥3.34 price screens above the ¥0.4000 fair value. Dashed = 300-day average. As of Aug 7, 2026.
Analysis
Guizhou Chitianhua Co (600227) currently trades at ¥3.34, while our model-based Fair Value estimate is ¥0.4000, implying the stock looks roughly 88.0% overvalued today. The Quality Score stands at 48/100 (below-average quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: medium).
Over the trailing twelve months, Guizhou Chitianhua Co generated revenue of 2.2B CNY at a net margin of -11.8%. Revenue grew 5.7% year over year. It earns a return on equity of -10.9%. Net debt stands at 835M CNY. Fundamentals as of Aug 7, 2026
Our scenario range runs from ¥0.2000 (bear case) to ¥0.6200 (bull case); at ¥3.34, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 38% below its 52-week high and 48% above its 52-week low, currently above its 200-day average. For context, the median of 10 Basic Materials peers we cover trades at -13% fair-value upside, at -88%, 600227 screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 12 models by family
Widest divergence: Growth DCF (¥1.82) versus Dividend Discount (¥0.3100). Highest evidence: Growth DCF (80).
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 7, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 48 · Market factors (momentum, volatility) 48
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Guizhou Chitianhua Co.,Ltd. engages in the chemical and pharmaceutical businesses in China. The company offers urea fertilizers; synthetic ammonia and ammonium sulfate; and sulfuric acid, industrial nitrogen, industrial ammonia, and industrial hydrogen, as well as basic chemical products and their deep-processed and by-products.
Full company description
Guizhou Chitianhua Co.,Ltd. engages in the chemical and pharmaceutical businesses in China. The company offers urea fertilizers; synthetic ammonia and ammonium sulfate; and sulfuric acid, industrial nitrogen, industrial ammonia, and industrial hydrogen, as well as basic chemical products and their deep-processed and by-products. It also produces and sells pharmaceuticals; medical equipment; and drugs for diabetes, cardiovascular, dermatology, gynecological, digestive system, endocrine, and psychotropic diseases. In addition, the company engages in the production of Chinese and western patent medicines; class II clinical laboratory analysis instruments; and sanitary products, as well as sales of self-produced products. Further, it is involved in the manufacture and sales of special and daily chemical products; provision of technical development, consultation, exchanges, and services; technology transfer and promotion; coal washing; sales of coal products; import and export of technology and goods; motor vehicle repair and maintenance; health care products; retailing of prepackaged foods; software technology development and services; data processing services; health consultation; production and sales of cosmetics; planting of Chinese herbal medicines; sales and storage services of cells; research on stem cell biotechnology and gene technology; production of biological products; investment in coal construction projects; and sales of industrial and mining products, mining equipment and spare parts. Guizhou Chitianhua Co.,Ltd. was formerly known as Guizhou Salvage Pharmaceutical Co.,Ltd. and changed its name to Guizhou Chitianhua Co.,Ltd. in May 2023. The company was founded in 1998 and is based in Guiyang, China.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Guizhou Chitianhua Co reported revenue of ¥2.2B in FY2025 versus ¥2.2B in FY2021, a compound −0.2%/yr. Reported net income was −¥276M in FY2025.
600227 screens 88% overvalued. Compare with Corteva, Inc →
Peer Group
Agricultural Inputs · 179 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Agricultural Inputs median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Agricultural Inputs stocks, each showing price versus our Fair Value estimate (as of Aug 7, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Corteva, Inc CTVA | $86.07 | $27.81 | -68% |
| Nutrien Ltd NTR | C$94.23 | C$81.69 | -13% |
| Qinghai Salt Lake Industry Co 000792 | ¥24.93 | ¥21.26 | -15% |
| CF Industries Holdings CF | $119.19 | $161.00 | +35% |
| SABIC Agri-Nutrients Company 2020 | 122.90 SAR | 127.31 SAR | +4% |
| Yara International ASA YAR | kr 451.30 | kr 67.25 | -85% |
| Yunnan Yuntianhua Co 600096 | ¥30.17 | ¥42.12 | +40% |
| Asia-potash International Investment (Guangzhou)Co.,Ltd., 000893 | ¥42.59 | ¥38.01 | -11% |
| Coromandel International Limited COROMANDEL | ₹2,034 | ₹1,129 | -44% |
| UPL Limited UPL | ₹594.75 | ₹387.06 | -35% |
Compare Guizhou Chitianhua Co with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Basic Materials stocks →
Frequently asked questions
Is Guizhou Chitianhua Co (600227) overvalued or undervalued?
What is the fair value of 600227?
What is the quality score of 600227?
What is the revenue of Guizhou Chitianhua Co (600227)?
What is the net profit margin of 600227?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Guizhou Chitianhua Co and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.